Pathway Genomics IPO

Pathway Genomics is a biotechnology company focused on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.

Register for Details

For more details on financing and valuation for Pathway Genomics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Who are Pathway Genomics's major investors?

International Business Machines

Pathway Genomics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/5/2016 Series E-1 $932.69MM $XXX.XX $XXX.XX
11/12/2014 Series D $470MM $XXX.XX $XXX.XX
4/1/2014 Series C $185MM $XXX.XX $XXX.XX
7/15/2009 Series B $72.48MM $XXX.XX $XXX.XX
7/1/2009 Series A $14MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Pathway Genomics

Forge green plus iconForge green minus icon

What is Pathway Genomics funding to date?

Pathway Genomics has raised $127.23MM with the following series:
$14MM for Series A, $72.48MM for Series B, $185MM for Series C, $470MM for Series D, $932.69MM for Series E-1, $14MM for Series A, $72.48MM for Series B, $185MM for Series C, $470MM for Series D, $932.69MM for Series E-1.
Forge green plus iconForge green minus icon

When was Pathway Genomics founded?

Pathway Genomics was founded in 2008.